Next, SSc lung and skin MFs were treated with the direct adenylyl cyclase (AC) activator, forskolin, or the cell‐permeable cAMP analog dibutyryl cAMP (db‐cAMP), the actions of which are depicted in the Figure 1B schematic. This evidence concerns the gene ASAH1 and systemic sclerosis.